Canopy Growth Corporation fell 1.60% in after-hours trading. The company reported strong top-line growth in the first quarter of fiscal 2026, driven by momentum in its Canada adult-use cannabis business and steady performance in its global medical cannabis business. Additionally, Canopy Growth appointed Margaret Shan Atkins to its Board of Directors, bringing extensive experience in retail strategy and operations, consumer goods, and finance.
Comments
No comments yet